RightFit
RecruitingPhase not listed

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether RNA, a type of genetic material found in tiny particles in blood, can help diagnose prostate cancer that is important to treat. It is for people who may have prostate cancer and are willing to have a prostate biopsy.

The aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have a blood PSA level above 4 ng/dl. PSA is a protein made by the prostate.
  • May have prostate cancer based on symptoms, a rectal exam, ultrasound, or MRI scans.
  • Are willing to have a prostate biopsy, which removes a small tissue sample for testing.

Who can't join

  • Have already been diagnosed with prostate cancer through a biopsy.
  • Have had another type of cancer in the past two years.
  • The study doctor thinks serious health problems may occur and interfere with the study.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Blood prostate-specific antigen PSA\>4ng/dl; 2. Patients suspected of having prostate cancer through clinical symptoms, digital rectal examination, ultrasound examination, magnetic resonance imaging. 3. The patient is willing to undergo prostate biopsy. Exclusion Criteria: 1. Previous diagnosis of prostate cancer through prostate biopsy; 2. History of other malignant tumors in the past two years; 3. According to the research physician''s judgment, serious complications may occur and affect the normal conduct of the experiment

Study sites (1)

IL